Sellas Life Sciences Group Inc (SLS)
$9.68 -4.68% Close Oct 30, 2026 Live
Sellas Life Sciences Group stock today
Sellas Life Sciences Group closed at $9.68 on October 30, 2026, down 4.68% on the day. Over the past year it returned +406.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.80 billion.
$5.00$10.00$15.00
NovJan 2026MarMayJulSep
| Period | SLS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -21.4% | -0.9% |
| 3 months | -5.9% | +2.1% |
| Year to date | +156.8% | +11.7% |
| 1 year | +406.8% | +12.4% |
| 3 years | +734.5% | +88.5% |
| 5 years | +11.4% | +76.0% |
Key statistics
- Market value
- $1.80B
- 52-week range
- $1.39 to $15.46
- Next report
- Nov 11, 2026 (estimated)
About Sellas Life Sciences Group
Sellas Life Sciences is a biopharmaceutical company developing immunotherapies for cancer.
Sector: Health Care
More on Sellas Life Sciences Group
- Financials: revenue, earnings and segmentsRevenue -87% in the year to Dec 2022
- Returns: what $1,000 became$1,000 five years ago is $1,114 today
No forecast, no recommendation. This page describes Sellas Life Sciences Group Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.